Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
With
Assistance Publique - Hôpitaux de Paris
Our cohort study aims at precisely documenting ophthalmic, auditory, vestibular, cogninitive alterations over time with phenotype/genotype correlation Ophthalmological assessment; Best corrected visual acuity, kynetic perimetry, microperimetry, colour contrast sensitivity, retinal multimodal imaging (fundus photograph, fundus autofluorescence, SD-OCT, OCTA, adaptive optics)
ENT assessment:
Tone and voice audiometry, Distortion product otoacoustic emissions Language assessment for children
Vestibular assessment:
Complete assessment of vestibular, canal and otolithic function Neuro-cognitive and visio spatial assessment Genetic: deep-genotyping using next generation sequencing
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with a molecular diagnosis of Usher syndrome type I, II or III or a clinical diagnosis of Usher syndrome type I, II or III which will then be confirmed by a molecular diagnosis
Health insurance beneficiary
Informed consent signed by the patient or their legal representatives
You may not be if
Patient or his/her legal representatives unable to understand the study and for whom informed consent cannot be obtained